| Literature DB >> 35666742 |
Yang-Hoon Chung1, Young-Seob Jeong2, Gati Lother Martin3, Min Seo Choi4, You Jin Kang1, Misoon Lee1, Ana Cho1, Bon Sung Koo1, Sung Hwan Cho1, Sang Hyun Kim1.
Abstract
BACKGROUND: Intraoperative hypertension and blood pressure (BP) fluctuation are known to be associated with negative patient outcomes. During robotic lower abdominal surgery, the patient's abdominal cavity is filled with CO2, and the patient's head is steeply positioned toward the floor (Trendelenburg position). Pneumoperitoneum and the Trendelenburg position together with physiological alterations during anesthesia, interfere with predicting BP changes. Recently, deep learning using recurrent neural networks (RNN) was shown to be effective in predicting intraoperative BP. A model for predicting BP rise was designed using RNN under special scenarios during robotic laparoscopic surgery and its accuracy was tested.Entities:
Mesh:
Year: 2022 PMID: 35666742 PMCID: PMC9200233 DOI: 10.1371/journal.pone.0269468
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Flow diagram outlining data filtering strategy.
Fig 2Overall process of the mean blood pressure hypertension prediction.
EMR-DB, electronic medical record database; ODS, operation data server.
Fig 3Recurrent neural network (RNN)-based model architecture.
Patient demographics based on non-hypertension and hypertension group classification.
| All cases | Non-hypertension | Hypertension | ||
|---|---|---|---|---|
| (n = 533) | (n = 254, 47.7%) | (n = 279, 52.3%) | ||
| Age (years) | 48 (40–61) | 46 (36–63) | 49 (43–60) | 0.044 |
| Sex (male/female) | 133/400 | 73/181 | 60/219 | 0.057 |
| Height (cm) | 161.11 ± 6.83 | 161.80 ± 7.34 | 160.47 ± 6.29 | 0.250 |
| Weight (kg) | 61.2 (54.6–69.8) | 61.0 (54.9–70.9) | 61.4 (54.1–61.4) | 0.590 |
| BMI (kg/m2) | 23.7 (21.4–26.4) | 23.4 (21.4–26.8) | 24.0 (21.4–26.1) | 0.653 |
| Type of surgery | <0.001 | |||
| Cystectomy (ovary) | 86 (16.1) | 55 (21.7) | 31 (11.1) | |
| Hysterectomy | 204 (38.3) | 66 (26.0) | 138 (49.5) | |
| Myomectomy | 75 (14.1) | 44 (17.3) | 31 (11.1) | |
| Prostatectomy | 129 (24.2) | 70 (27.6) | 59 (21.1) | |
| Salpingo-oophorectomy | 39 (7.3) | 19 (7.5) | 20 (7.2) | |
| ASA classification | 0.213 | |||
| 1 | 296 (55.5) | 138 (54.3) | 158 (56.6) | |
| 2 | 207 (38.8) | 97 (38.2) | 110 (39.4) | |
| 3 | 30 (5.6) | 19 (7.5) | 11 (3.9) |
The data are presented as the mean ± standard deviation, median (interquartile range), or n (%)
BMI, body mass index; ASA, American Society of Anesthesiologists
aStatistical significance was tested using the Mann-Whitney U test (age, weight, and BMI), t-test (height), or chi-squared test (type of surgery and ASA classification)
Underlying comorbidities of patients based on non-hypertension and hypertension group classification.
| Underlying diseases | All cases | Non-hypertension | Hypertension | |
|---|---|---|---|---|
| (n = 533) | (n = 254) | (n = 279) | ||
| Cardiovascular | ||||
| Hypertension | 140 (26.3) | 68 (26.8) | 72 (25.8) | 0.844 |
| Atrial fibrillation | 8 (1.5) | 4 (1.6) | 4 (1.4) | 1.000 |
| Coronary artery disease | 3 (0.6) | 3 (1.2) | 0 (0.0) | 0.108 |
| Angina pectoris | 4 (0.8) | 3 (1.2) | 1 (0.4) | 0.352 |
| Respiratory | ||||
| Asthma | 22 (4.1) | 8 (3.1) | 14 (5.0) | 0.384 |
| COPD | 3 (0.6) | 1 (0.4) | 2 (0.7) | 1.000 |
| Gastrointestinal | ||||
| Liver cirrhosis | 4 (0.8) | 4 (1.6) | 0 (0.0) | 0.051 |
| Renal | ||||
| Chronic kidney injury | 9 (1.7) | 8 (3.1) | 1 (0.4) | 0.160 |
| End-stage renal disease | 2 (0.4) | 1 (0.4) | 1 (0.4) | 1.000 |
| Endocrine | ||||
| Diabetes mellitus | 46 (8.6) | 26 (10.2) | 20 (7.2) | 0.220 |
| Thyroid disease | 28 (5.3) | 14 (5.5) | 14 (5.0) | 0.847 |
| Neurologic | ||||
| Cerebrovascular disease | 10 (1.9) | 3 (1.2) | 7 (2.5) | 0.345 |
The data are presented as n (%)
COPD, chronic obstructive pulmonary disease
aStatistical significance between the groups were tested using the chi-squared test (hypertension, asthma, diabetes mellitus, and thyroid disease) or Fisher’s exact test (atrial fibrillation, coronary artery disease, angina pectoris, COPD, liver cirrhosis, chronic kidney injury, end-stage renal disease, and cerebrovascular disease)
Underlying comorbidities of patients based on surgery type.
| Underlying diseases | Cystectomy | Hysterectomy | Myomectomy | Prostatectomy | Salpingo-oophorectomy | |
|---|---|---|---|---|---|---|
| (n = 86) | (n = 204) | (n = 75) | (n = 129) | (n = 39) | ||
| Cardiovascular | ||||||
| Hypertension | 4 (4.7) | 40 (19.6) | 6 (8.0) | 81 (62.8) | 9 (23.1) | <0.001* |
| Atrial fibrillation | 1 (1.2) | 1 (0.5) | 0 (0.0) | 6 (4.7) | 0 (0.0) | 0.018* |
| Coronary artery disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (2.3) | 0 (0.0) | 0.051 |
| Angina pectoris | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (3.1) | 0 (0.0) | 0.013* |
| Respiratory | ||||||
| Asthma | 2 (2.3) | 10 (4.9) | 4 (5.3) | 5 (3.9) | 1 (2.6) | 0.817 |
| COPD | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (2.3) | 0 (0.0) | 0.051 |
| Gastrointestinal | ||||||
| Liver cirrhosis | 1 (1.2) | 1 (0.5) | 0 (0.0) | 2 (1.6) | 0 (0.0) | 0.671 |
| Renal | ||||||
| Chronic kidney injury | 1 (1.2) | 0 (0.0) | 1 (1.3) | 7 (5.4) | 0 (0.0) | 0.004* |
| End-stage renal disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.6) | 0 (0.0) | 0.179 |
| Endocrine | ||||||
| Diabetes mellitus | 1 (1.2) | 16 (7.8) | 2 (2.7) | 27 (20.9) | 0 (0.0) | <0.001* |
| Thyroid disease | 2 (2.3) | 16 (7.8) | 2 (2.7) | 3 (2.3) | 5 (12.8) | 0.018* |
| Neurologic | ||||||
| Cerebrovascular disease | 0 (0.0) | 3 (1.5) | 0 (0.0) | 6 (4.7) | 1 (2.6) | 0.067 |
The data are presented as n (%)
COPD, chronic obstructive pulmonary disease
aStatistically significant differences between the groups were analyzed using the chi-squared test.
Fig 4Receiver operating characteristic (ROC) curve of the proposed model with D9:1.
Performance of the proposed model with different datasets.
| Dataset | F1 (%) | Precision (%) | Recall (%) | |||
|---|---|---|---|---|---|---|
| Non-H | H | Non-H | H | Non-H | H | |
| D | 71.87 | 70.60 | 68.78 | 74.61 | 75.26 | 67.00 |
| D | 72.53 | 55.39 | 64.50 | 70.95 | 82.86 | 45.42 |
| D | 70.72 | 66.78 | 78.55 | 60.50 | 64.32 | 74.52 |
| D | 57.61 | 70.08 | 47.83 | 82.43 | 72.42 | 60.94 |
| D | 75.16 | 71.34 | 93.33 | 58.54 | 62.91 | 91.29 |
| D9:1 | 82.54 | 74.52 | 81.76 | 76.91 | 83.33 | 72.27 |
| D8:2 | 73.75 | 68.09 | 73.83 | 68.91 | 73.67 | 67.29 |
| D7:3 | 74.49 | 68.66 | 71.55 | 72.75 | 77.67 | 65.00 |
| Mac.Avg. | 72.33 | 68.18 | 72.52 | 70.70 | 74.06 | 67.97 |
| Mic.Avg. | 70.22 | 67.50 | 68.46 | 72.15 | 74.31 | 65.40 |
Non-H, non-hypertension; H, hypertension
aD: a dataset in which all instances of robotic salpingo-oophorectomy surgery were used as test data.
bD: a dataset in which all instances of robotic prostatectomy surgery were used as test data.
cD: a dataset in which all instances of robotic myomectomy surgery were used as test data.
dD: a dataset in which all instances of robotic hysterectomy surgery were used as test data.
eD: a dataset in which all instances of robotic cystectomy surgery were used as test data.
fD7:3, D8:2, D9:1: datasets in which the train:validation ratios were 7:3, 8:2, and 9:1, respectively.